Expression and activity of 11β-hydroxysteroid dehydrogenase type 1 enzyme in subcutaneous and visceral adipose tissue of prepubertal children

Hormone Research

Volumn 71, Issue 2, 2009, Pages 89-93

  Mericq, Verónica ^a,d   Medina, Pablo ^a   Bouwman, Carolien ^a   Johnson, M Cecilia ^a   Godoy, Jorge ^c   López, Teresa ^b   Iñiguez, Germán ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL SAN BORJA ARRIARÁN   (Chile)

^c HOSPITAL LUIS CALVO MACKENNA   (Chile)

^d UNIVERSITY OF CHILE   (Chile)

Author keywords

11 hydroxysteroid dehydrogenase type 1; Adipose tissue; Small for gestational age children

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; HYDROCORTISONE; GLUCOCORTICOID; HSD11B1 PROTEIN, HUMAN; INSULIN;

ABDOMINAL SURGERY; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTIVE SURGERY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LOW BIRTH WEIGHT; MALE; OBESITY; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SMALL FOR DATE INFANT; SUBCUTANEOUS FAT; TISSUE LEVEL; WEIGHT GAIN; BIOSYNTHESIS; CARDIOVASCULAR DISEASE; ENZYMOLOGY; GENE EXPRESSION REGULATION; LIVER; METABOLISM; PHYSIOLOGY; SUBCUTANEOUS TISSUE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHILD; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; INSULIN; INTRA-ABDOMINAL FAT; LIVER; MALE; OBESITY; SUBCUTANEOUS TISSUE;

EID: 58149149355     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000183897     Document Type: Article

References (18)

1. Barker DJ: Fetal origins of coronary heart disease. BMJ 1995;311:171-174.
2. Hales CN, Barker DJ, Clark PM, et al: Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991;303:1019-1022.
3. Soto N, Bazaes RA, Pena V, et al: Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort. J Clin Endocrinol Metab 2003;88:3645-3650.
4. Ibanez L, Ong K, Dunger DB, de Zegher F: Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children. J Clin Endocrinol Metab 2006;91:2153-2158.
5. Johnson MC, Vega M, Vantman D, Troncoso JL, Devoto L: Regulatory role of angiotensin II on progesterone production by cultured human granulosa cells. Expression of angiotensin II type-2 receptor. Mol Hum Reprod 1997;3:663-668.
6. Schmittgen TD, Zakrajsek BA: Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. J Biochem Biophys Methods 2000;46:69-81.
7. McTernan CL, Draper N, Nicholson H, et al: Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J Clin Endocrinol Metab 2001;86:4979-4983.
8. Masuzaki H, Paterson J, Shinyama H, et al: A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-2170.
9. Paterson JM, Morton NM, Fievet C, et al: Metabolic syndrome without obesity: hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci USA 2004;101:7088-7093.
10. Liu Y, Nakagawa Y, Wang Y, et al: Increased glucocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice. Diabetes 2005;54:32-40.
11. Rask E, Walker BR, Soderberg S, et al: Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 2002;87:3330-3336.
12. Valsamakis G, Anwar A, Tomlinson JW, et al:11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus. J Clin Endocrinol Metab 2004;89:4755-4761.
13. Draper N, Echwald SM, Lavery GG, et al: Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism. J Clin Endocrinol Metab 2002;87:4984-4990.
14. Wiegand S, Richardt A, Remer T, et al: Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys. Eur J Endocrinol 2007;157:319-324.
15. Paulsen SK, Pedersen SB, Fisker S, Richelsen B:11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity (Silver Spring) 2007;15:1954-1960.
16. Berthiaume M, Laplante M, Festuccia W, et al: Depot-specific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11beta-hydroxysteroid dehydrogenase type 1. Endocrinology 2007;148:2391-2397.
17. Tomlinson JW, Sherlock M, Hughes B, et al: Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis. J Clin Endocrinol Metab 2007;92:857-864.
18. McMillen IC, Warnes KE, Adams MB, Robinson JS, Owens JA, Coulter CL: Impact of restriction of placental and fetal growth on expression of 11beta-hydroxysteroid dehydrogenase type 1 and type 2 messenger ribonucleic acid in the liver, kidney, and adrenal of the sheep fetus. Endocrinology 2000;141:539-543.